Literature DB >> 7704066

Reducing anxiety in newly diagnosed cancer patients: a pilot program.

M E Wells, R P McQuellon, J S Hinkle, J M Cruz.   

Abstract

This study tested the efficacy of a pilot orientation program in reducing distress levels of patients with newly diagnosed cancer. Thirty-three consecutive patients were randomly assigned to an intervention or to a usual-care control group. The intervention group received a clinic tour, general information, and the opportunity to pose questions to an oncology counselor. The dependent variables were measured by the Profile of Mood States-Short Form-Total Mood Disturbance Scale and the State Trait Anxiety Inventory. Scores on the dependent measures were significantly lower in the intervention group. These results suggest that a simple orientation can greatly benefit patients with newly diagnosed cancer. The orientation may reduce anxiety and overall distress by helping patients manage novelty and unpredictability in the unfamiliar clinic setting. This intervention can be delivered within the context of a busy hematology/oncology outpatient clinic.

Entities:  

Mesh:

Year:  1995        PMID: 7704066

Source DB:  PubMed          Journal:  Cancer Pract        ISSN: 1065-4704


  3 in total

1.  Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance.

Authors:  Patricia A Parker; John W Davis; David M Latini; George Baum; Xuemei Wang; John F Ward; Deborah Kuban; Steven J Frank; Andrew K Lee; Christopher J Logothetis; Jeri Kim
Journal:  BJU Int       Date:  2015-04-21       Impact factor: 5.588

2.  Evaluation of an oncology outpatient orientation program: patient satisfaction and outcomes.

Authors:  Melanie D Gallant; Larry M Coutts
Journal:  Support Care Cancer       Date:  2003-10-17       Impact factor: 3.603

3.  Effects and feasibility of a multi-disciplinary orientation program for newly registered cancer patients: design of a randomised controlled trial.

Authors:  Raymond Chan; Joan Webster; Linda Bennett
Journal:  BMC Health Serv Res       Date:  2009-11-11       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.